Holen Sie sich die Stockscreener-App
43.88
3.41%
-1.5509
Vorhandelsmarkt:
43.88
-0.0041
-0.01%
Schlusskurs vom Vortag:
$45.44
Offen:
$44.36
24-Stunden-Volumen:
29,389
Relative Volume:
2.56
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.47%
1M Leistung:
+7.17%
6M Leistung:
+33.79%
1J Leistung:
+4.59%
1-Tages-Spanne:
$43.10
$44.70
1-Wochen-Bereich:
$43.10
$45.47
52-Wochen-Spanne:
$27.20
$45.47
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GNOM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
43.88 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
683.34 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.69 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.42 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
632.08 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
Biotechnology: Pioneering The Future Of Medicine - Seeking Alpha
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Update - Defense World
Discipline and Rules-Based Execution in GNOM Response - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure - MSN
6 Best AI Drug Discovery Stocks in 2025 - StocksToTrade
CRSP Stock: How to Invest in CRISPR Therapeutics - The Motley Fool
HighTower Advisors LLC Acquires 2,184 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Re-rating Opportunities in Health Care Amid Sector Rotation and Regulatory Risk - AInvest
Investment Guide to Genetics Stocks and ETFs - NAI500
Investing in the DNA of Tomorrow: Explore Gene Stocks and Genomics ETFs - Investing News Network
How to Invest in Gene Stocks and ETFs - Nasdaq
The Next Big Theme: August 2025 - Seeking Alpha
Global X Announces Five ETF Reverse Stock Splits - Eastern Progress
7 Best Biotech ETFs to Buy Now - US News Money
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Global X Fds Genomics & Biotechnology Etf To Carry Out 1-for-4 Reverse Stock Split On September 2nd, 2025 - 富途牛牛
The Next Big Theme: July 2025 - Seeking Alpha
Stratos Wealth Partners LTD. Buys 2,865 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - 富途牛牛
Middlefield Healthcare Dividend ETF: A Strategic Play on Dividend Income and Sector Resilience - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Price Passes Above 200-Day Moving Average of $13.45 - 富途牛牛
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Position Increased by Portland Global Advisors LLC - 富途牛牛
(GNOM) Investment Analysis and Advice - news.stocktradersdaily.com
Jack Reed Net Worth - Quiver Quantitative
The long game: ASX ETFs to target amidst an ageing population - The Motley Fool Australia
Global X Genomics & Biotechnology ETF declares semi-annual distribution of $0.0083 - MSN
3 ASX ETFs that could be good value right now - The Motley Fool Australia
Oppenheimer Asset Management Inc. Has $659,000 Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
The Next Big Theme: June 2025 - Global X ETFs
Learn to Evaluate (GNOM) using the Charts - news.stocktradersdaily.com
Gene Therapy Stocks Fall Amid More Turmoil at FDA - Barron's
Should we bet on a biotech revival? - marketscreener.com
Douglas Dynamics, Inc. (NYSE:PLOW) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Rush Street Interactive (NYSE:RSI) Raised to Strong-Buy at Wall Street Zen - Defense World
15,215 Shares in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Acquires Shares of 10,644 Mastech Digital, Inc. (NYSE:MHH) - Defense World
Citadel Advisors LLC Acquires New Position in Global X Aging Population ETF (NASDAQ:AGNG) - Defense World
8,047 Shares in Innovator U.S. Equity 5 to 15 Buffer ETF – Quarterly (BATS:EALT) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Grows Stake in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Two Sigma Investments LP Raises Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Bank of America Corp DE Cuts Stock Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
(GNOM) Trading Advice - news.stocktradersdaily.com
D. E. Shaw & Co. Inc. Purchases New Position in CureVac (NASDAQ:CVAC) - Defense World
BNP Paribas Financial Markets Buys Shares of 23,292 Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $643,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
NETSTREIT Corp. (NYSE:NTST) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Topgolf Callaway Brands Corp. (NYSE:MODG) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 905 Shares of IMAX Co. (NYSE:IMAX) - Defense World
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):